| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.83B | 4.97B | 4.43B | 1.66B | 55.00M | 0.00 |
| Gross Profit | 121.00M | -1.20B | -2.03B | -3.12B | -465.00M | -29.00M |
| EBITDA | -2.30B | -3.39B | -4.27B | -5.99B | -4.46B | -981.00M |
| Net Income | -3.58B | -4.75B | -5.43B | -6.75B | -4.69B | -1.02B |
Balance Sheet | ||||||
| Total Assets | 15.22B | 15.41B | 16.78B | 17.88B | 22.29B | 4.60B |
| Cash, Cash Equivalents and Short-Term Investments | 7.09B | 7.70B | 9.37B | 11.57B | 18.13B | 2.98B |
| Total Debt | 4.97B | 5.74B | 4.92B | 1.81B | 1.61B | 180.00M |
| Total Liabilities | 10.13B | 8.85B | 7.64B | 4.08B | 2.78B | 5.99B |
| Stockholders Equity | 5.07B | 6.56B | 9.14B | 13.80B | 19.51B | -1.38B |
Cash Flow | ||||||
| Free Cash Flow | -489.00M | -2.86B | -5.89B | -6.42B | -4.42B | -1.76B |
| Operating Cash Flow | 1.08B | -1.72B | -4.87B | -5.05B | -2.62B | -848.00M |
| Investing Cash Flow | -2.89B | -1.98B | -2.51B | -1.37B | -1.79B | -914.00M |
| Financing Cash Flow | 851.00M | 1.14B | 3.13B | 99.00M | 19.83B | 2.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.53T | 317.59 | 7.03% | ― | -1.56% | -59.09% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | $22.58B | -6.01 | -65.28% | ― | 28.21% | 44.43% | |
55 Neutral | $17.53B | 27.85 | 6.53% | ― | -10.00% | -54.75% | |
50 Neutral | $18.49B | -43.98 | -9.01% | ― | 86.57% | 51.35% | |
45 Neutral | $11.61B | -3.43 | -296.45% | ― | 14.94% | 2.53% | |
41 Neutral | $4.07B | -1.10 | -61.12% | ― | 45.86% | 22.13% |
On November 6, 2025, Rivian Automotive‘s Board of Directors approved a new performance-based stock option for CEO Dr. Robert J. Scaringe, replacing a previous award from 2021. The new option allows the purchase of up to 36.5 million shares, contingent on achieving significant stock price and financial performance goals, designed to retain and incentivize Dr. Scaringe as Rivian progresses its technology roadmap and launches new products. Additionally, Dr. Scaringe received a profits interest award from Mind Robotics, a subsidiary of Rivian, providing him with a 10% economic interest once certain profit thresholds are met.
Rivian Automotive, Inc. announced on October 23, 2025, that it has agreed to settle a securities class action litigation from 2022, which was pending in the United States District Court for the Central District of California. The company, while denying any wrongdoing, has agreed to pay $250 million to resolve the claims, allowing it to focus its resources on the upcoming launch of its mass market R2 vehicle in the first half of 2026. The settlement is subject to court approval and will be funded through a combination of insurance and cash on hand.
On October 2, 2025, Rivian announced its production and delivery figures for the quarter ending September 30, 2025, with 10,720 vehicles produced and 13,201 delivered, aligning with its outlook. The company narrowed its 2025 delivery guidance to 41,500 to 43,500 vehicles and plans to release its third-quarter financial results on November 4, 2025, followed by an audio webcast to discuss business performance and outlook.